Objectives of the CRT Meeting
The May and July CRT meetings aim to discuss implementation of science in cardiovascular medicine and define a vision for the promotion and adoption of evidence-based practices by integrating various ESC activities into routine health to improve patient outcomes.
The May meeting will focus on the barriers that may limit the widespread adoption of the ESC Guidelines and delve into these challenges on local, regional and national levels. We will discuss how data collection and educational activities can help identify gaps in implementation, and discuss how healthcare systems and socio-economic aspects may impact the adoption and acceptance of guideline-indicated treatments.
The July meeting will propose innovative mechanisms and quality of care improvement strategies aimed at addressing the ‘evidence-practice’ gap, with the ultimate goal of proposing a comprehensive implementation programme to improve patient care.
Draft Programme
Academic Chairpersons
- Dr. Suleman Aktaa
- Prof. Eva Prescott
- Prof. Thomas F. Lüscher (ESC President-elect and ESC Chair of the CRT)
Industry Chairpersons
- Jessica Dolan (GE Healthcare)
- Dr. Ricardo Rocha (Intellia Therapeutics)
- Dr. Tamara Krcmar (Servier International)
- Prof. Alexandra Goncalves /BMS (Industry Chair of the CRT)
Day 1: 29 May 2024 14:00–18:20 CEST
|
Time |
Session |
Speaker |
|---|---|---|
|
12:00-14:00 |
Arrival and buffet lunch |
|
|
14:00-14:05 |
Welcome from the CRT Chairpersons |
Alexandra Goncalves, Thomas F. Lüscher |
|
14:05 -18:20 |
SESSION 1.1 – Financial and structural aspects of guideline implementation Moderated by : Suleman Aktaa and Jessica Dolan (GE Healthcare) |
|
|
14:05-14:35 |
ESC guidelines and the aspiration of the ESC virtuous circle (Guidelines, Quality Indicators, Education, Registries) |
Eva Prescott |
|
14:35-14:55 |
Global implementation of guidelines |
Salim Yusuf |
|
14:55-15:25 |
Industry perspectives on guideline implementation |
Ricardo Rocha (Intellia Therapeutics) Alphons Vincent (Medtronic) |
|
15:25-15:40 |
Socioeconomic barriers to access to care |
Chris Gale |
|
15:40-15:55 |
Role of registries in identifying gaps in GL implementation |
Suleman Aktaa |
|
15:55-16:10 |
Multidisciplinary approach to facilitate guideline implementation |
Harriette Van Spall (via zoom) |
|
16:10-16 :25 |
PANEL DISCUSSION |
|
|
16:30-16:45 |
Coffee break |
|
|
16:45-17:15 |
BREAKOUT SESSIONS What are the main challenges for guideline implementation? |
|
|
|
Group 1: Within healthcare systems |
Lead: Piotr Jankowski Rapporteur: Andre Krueger (Novartis) |
|
|
Group 2: Financial barriers, locally and nationally |
Lead: Nardiner Bhalla (BMS) |
|
|
Group 3: The physicians |
Lead: Elena Arbelo |
|
17:15-17:20 |
Report from breakout session 1 – 10 mins |
Rapporteur: Andre Krueger (Novartis) |
|
17:20-17:25 |
Report from breakout session 2 – 10 mins |
Rapporteur: Julie Sanders |
|
17:25-17:30 |
Report from breakout session 3 – 10 mins |
Rapporteur: Chris Plummer |
|
Session I.2: Guideline implementation from patient perspective Moderated by: Suleman Aktaa and Jessica Dolan (GE Healthcare) |
||
|
17:30-17:45 |
Patient perspective & PREMs |
Richard Mindham |
|
17:45-18:00 |
Adherence issues |
Tamara Krcmar (Servier International) |
|
18:00-18:15 |
Role of nurse-led clinics in addressing patient adherence and implementation of guidelines |
Izabella Uchmanowicz |
|
18:15-18:30 |
PANEL DISCUSSION |
|
|
18:30-18:40 |
Wrap-up and summary day 1 – Outlook to day 2 |
CRT Chairpersons : Alexandra Goncalves, Thomas F. Lüscher |
|
END OF DAY 1 |
||
|
19:15 20:00 |
APERITIF DINNER |
|
Day 2: 30 May 2024 08:20–12:30 CEST
|
Time |
Session |
Speaker |
|---|---|---|
|
08:20-08:30 |
Summary of day 1 |
Eva Prescott Ricardo Rocha (Intellia Therapeutics) |
|
08:30 - 12:10 |
SESSION 2: ESC perspective of Guidelines implementation: challenges & learnt lessons Moderated by : Eva Prescott, Ricardo Rocha (Intellia Therapeutics) |
|
|
08:30-09:00 |
Highlights from questionnaire |
Suleman Aktaa |
|
09:00-09:30 |
Guideline implementation in eastern European & developing countries: a testimony from Slovakia and Syria |
Amr Abdin |
|
09:30-09:45 |
Does the EU regulatory system facilitate or hinder equal access to novel cardiovascular drugs across Europe? |
Alar Irs, EMA |
|
09:45-10:00 |
Appropriate implementation of ESC guidelines - what do Atlas data tell us? | Panos Vardas |
|
10:00-10:15 |
Different healthcare system in Europe |
TBD |
|
10:15-10:30 |
EuroAspire registry: lessons learned on implementation |
John William Mcevoy |
|
10:30-10:45 |
Current implementation of AF guidelines and ESC initiatives: the STEEER AF Study |
Isabelle C. van Gelder (via zoom) |
|
10:45-11:00 |
Coffee break |
|
|
11:00-11:45 |
BREAKOUT SESSIONS How can we collectively work to improve quality of care? |
|
|
Group 4: Access to care: Optimizing health care systems |
Lead: Gorav Batra Rapporteur: Francisco Javier Rossello Lozano |
|
|
Group 5: Access to care: Optimizing affordability |
Lead: Kevin O’Gallagher Rapporteur: TBD |
|
|
Group 6: Access to care: Optimizing individual clinical care |
Lead: TBD |
|
|
11:45-11:55 |
Report from breakout session 4 – 10 mins |
Rapporteur: Francisco Javier Rossello Lozano |
|
11:55-12:05 |
Report from breakout session 5 – 10 mins |
Rapporteur: TBD |
|
12:05-12:15 |
Report from breakout session 6 – 10 mins |
Rapporteur: Christian Hassager |
|
12:15 -12:20 |
Wrap-up, conclusions, next steps for publication |
CRT Chairpersons: Alexandra Goncalves, Thomas F. Lüscher |
|
END OF DAY 2 |
||
|
12:20 |
Buffet lunch and departures |
|
Biographies
- Prof. Thomas F. LÜSCHER, UK
- Prof. Alexandra GONCALVES, BMS
- Dr. Alar IRS, Estonia
- Dr. Alphons VINCENT, Medtronic
- Associate Professor. Amr ABDIN, Syria and Germany
- Prof. Bill MCEVOY, Ireland
- Prof. Chris GALE, UK
- Dr. Chris PLUMMER, UK
- Prof. Izabella UCHMANOWICZ, Poland
- Prof. Panos VARDAS, Greece
- Prof. Piotr JANKOWSKI, Poland
- Mr. Richard MINDHAM, UK
- Prof. Ronen BEERI, FESC, FEACVI, Israel
- Dr. Suleman AKTAA, UK
Our mission: To reduce the burden of cardiovascular disease.